Evaluation of ticlopidine, a novel inhibitor of platelet aggregation, in heart transplant recipients

Transplantation. 1993 May;55(5):1195-6. doi: 10.1097/00007890-199305000-00050.

Authors

M de Lorgeril¹, P Boissonnat, G Dureau, J Guidollet, S Renaud

Affiliation

¹ INSERM U.63, Laboratory of Biochemistry, Hôpital Cardiologique, Lyon, France.

PMID: 8497902
DOI: 10.1097/00007890-199305000-00050

No abstract available

MeSH terms

Adult
Aged
Coronary Artery Disease / prevention & control
Drug Evaluation
Female
Heart Transplantation / pathology
Heart Transplantation / physiology*
Humans
Male
Middle Aged
Platelet Aggregation / drug effects
Ticlopidine / adverse effects
Ticlopidine / pharmacology*
Ticlopidine / therapeutic use

Substances

Ticlopidine